William H. Hildebrand - Publications

University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Microbiology Biology

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 DeVette CI, Andreatta M, Bardet W, Cate SJ, Jurtz VI, Jackson KW, Welm AL, Nielsen M, Hildebrand WH. NetH2pan: A Computational Tool to Guide MHC peptide prediction on Murine Tumors. Cancer Immunology Research. PMID 29615400 DOI: 10.1158/2326-6066.CIR-17-0298  0.44
2017 Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, ... ... Hildebrand WH, et al. The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Reports. 19: 1394-1405. PMID 28514659 DOI: 10.1016/j.celrep.2017.04.059  0.52
2016 Kaabinejadian S, McMurtrey CP, Kim S, Jain R, Bardet W, Schafer FB, Davenport JL, Martin AD, Diamond MS, Weidanz JA, Hansen TH, Hildebrand WH. Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. Journal of Immunology (Baltimore, Md. : 1950). 196: 4263-73. PMID 27183642 DOI: 10.4049/jimmunol.1501821  0.96
2016 Trolle T, McMurtrey CP, Sidney J, Bardet W, Osborn SC, Kaever T, Sette A, Hildebrand WH, Nielsen M, Peters B. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. Journal of Immunology (Baltimore, Md. : 1950). 196: 1480-7. PMID 26783342 DOI: 10.4049/jimmunol.1501721  0.96
2015 Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald GC, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Molecular Cancer Therapeutics. PMID 26719579 DOI: 10.1158/1535-7163.MCT-15-0658  0.96
2015 Abelin JG, Trantham PD, Penny SA, Patterson AM, Ward ST, Hildebrand WH, Cobbold M, Bai DL, Shabanowitz J, Hunt DF. Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry. Nature Protocols. 10: 1308-18. PMID 26247297 DOI: 10.1038/nprot.2015.086  0.96
2014 Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cedeño S, Plana M, Mothe B, Brander C, ... ... Hildebrand WH, et al. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. Journal of Virology. 88: 12992-3004. PMID 25165114 DOI: 10.1128/JVI.01914-14  0.96
2014 Piazza P, Campbell D, Marques E, Hildebrand WH, Buchli R, Mailliard R, Rinaldo CR. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes. Clinical and Experimental Immunology. 177: 696-702. PMID 24816171 DOI: 10.1111/cei.12373  0.96
2014 Kim S, Pinto AK, Myers NB, Hawkins O, Doll K, Kaabinejadian S, Netland J, Bevan MJ, Weidanz JA, Hildebrand WH, Diamond MS, Hansen TH. A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. European Journal of Immunology. 44: 1936-46. PMID 24723377 DOI: 10.1002/eji.201444450  0.96
2014 May NA, Wang Q, Balbo A, Konrad SL, Buchli R, Hildebrand WH, Schuck P, Hudson AW. Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules Journal of Virology. 88: 3298-3308. PMID 24390327 DOI: 10.1128/JVI.02639-13  0.96
2014 Borchers CH, Kast J, Foster LJ, Siu KW, Overall CM, Binkowski TA, Hildebrand WH, Scherer A, Mansoor M, Keown PA. The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies. Journal of Proteomics. 100: 60-7. PMID 23933161 DOI: 10.1016/j.jprot.2013.08.001  0.96
2013 Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH. Identification of class I HLA T cell control epitopes for West Nile virus. Plos One. 8: e66298. PMID 23762485 DOI: 10.1371/journal.pone.0066298  0.96
2012 Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, Hildebrand WH, Buchli R. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. Aids (London, England). 26: F21-9. PMID 22617051 DOI: 10.1097/QAD.0b013e328355fe8f  0.96
2012 Hoof I, van Baarle D, Hildebrand WH, Keşmir C. Proteome sampling by the HLA class I antigen processing pathway. Plos Computational Biology. 8: e1002517. PMID 22615552 DOI: 10.1371/journal.pcbi.1002517  0.96
2012 Sette A, Sidney J, Southwood S, Moore C, Berry J, Dow C, Bradley K, Hoof I, Lewis MG, Hildebrand WH, McMurtrey CP, Wilson NA, Watkins DI, Mothé BR. A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules. Immunogenetics. 64: 421-34. PMID 22322672 DOI: 10.1007/s00251-011-0598-5  0.96
2011 Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreño J, Bach V, Zuniga R, Pérez-Álvarez S, Berger CT, Puertas MC, Martinez-Picado J, Rolland M, Farfan M, Szinger JJ, ... Hildebrand WH, et al. Definition of the viral targets of protective HIV-1-specific T cell responses. Journal of Translational Medicine. 9: 208. PMID 22152067 DOI: 10.1186/1479-5876-9-208  0.96
2011 Weidanz JA, Hawkins O, Verma B, Hildebrand WH. TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. International Reviews of Immunology. 30: 328-40. PMID 22053972 DOI: 10.3109/08830185.2011.604880  0.96
2011 Weidanz JA, Hildebrand WH. Expanding the targets available to therapeutic antibodies via novel disease-specific markers. International Reviews of Immunology. 30: 312-27. PMID 22053971 DOI: 10.3109/08830185.2011.608136  0.96
2011 Buranapraditkun S, Hempel U, Pitakpolrat P, Allgaier RL, Thantivorasit P, Lorenzen SI, Sirivichayakul S, Hildebrand WH, Altfeld M, Brander C, Walker BD, Phanuphak P, Hansasuta P, Rowland-Jones SL, Allen TM, et al. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. Plos One. 6: e23603. PMID 21887282 DOI: 10.1371/journal.pone.0023603  0.96
2011 Greene JM, Wiseman RW, Lank SM, Bimber BN, Karl JA, Burwitz BJ, Lhost JJ, Hawkins OE, Kunstman KJ, Broman KW, Wolinsky SM, Hildebrand WH, O'Connor DH. Differential MHC class I expression in distinct leukocyte subsets. Bmc Immunology. 12: 39. PMID 21762519 DOI: 10.1186/1471-2172-12-39  0.96
2011 Reed JS, Sidney J, Piaskowski SM, Glidden CE, León EJ, Burwitz BJ, Kolar HL, Eernisse CM, Furlott JR, Maness NJ, Walsh AD, Rudersdorf RA, Bardet W, McMurtrey CP, O'Connor DH, ... Hildebrand WH, et al. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection. Immunogenetics. 63: 789-807. PMID 21732180 DOI: 10.1007/s00251-011-0541-9  0.96
2011 Lyke KE, Fernández-Viňa MA, Cao K, Hollenbach J, Coulibaly D, Kone AK, Guindo A, Burdett LA, Hartzman RJ, Wahl AR, Hildebrand WH, Doumbo OK, Plowe CV, Sztein MB. Association of HLA alleles with Plasmodium falciparum severity in Malian children Tissue Antigens. 77: 562-571. PMID 21447146 DOI: 10.1111/j.1399-0039.2011.01661.x  0.96
2011 Gleimer M, Wahl AR, Hickman HD, Abi-Rached L, Norman PJ, Guethlein LA, Hammond JA, Draghi M, Adams EJ, Juo S, Jalili R, Gharizadeh B, Ronaghi M, Garcia KC, Hildebrand WH, et al. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. Journal of Immunology (Baltimore, Md. : 1950). 186: 1575-88. PMID 21209280 DOI: 10.4049/jimmunol.1002990  0.96
2011 Zhang GL, O'Connor DH, Budde ML, Hildebrand WH, Lhost JJ, Brusic V. PRED mafa: A system for prediction of peptide binding to several MHC class i molecules in cynomolgus macaques 2011 Acm Conference On Bioinformatics, Computational Biology and Biomedicine, Bcb 2011. 602-606. DOI: 10.1145/2147805.2147908  0.96
2010 Piazza P, McMurtrey CP, Lelic A, Cook RL, Hess R, Yablonsky E, Borowski L, Loeb MB, Bramson JL, Hildebrand WH, Rinaldo CR. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. Plos One. 5: e15343. PMID 21179445 DOI: 10.1371/journal.pone.0015343  0.96
2010 Augustine AD, Cassetti MC, Ennis FA, Harris E, Hildebrand WH, Repik PM. NIAID workshop on Flavivirus immunity. Viral Immunology. 23: 235-40. PMID 20565288 DOI: 10.1089/vim.2009.0114  0.96
2010 Wang S, Buchli R, Schiller J, Gao J, VanGundy RS, Hildebrand WH, Eckels DD. Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity. World Journal of Gastroenterology : Wjg. 16: 1953-69. PMID 20419832 DOI: 10.3748/wjg.v16.i16.1953  0.96
2010 Kim S, Li L, McMurtrey CP, Hildebrand WH, Weidanz JA, Gillanders WE, Diamond MS, Hansen TH. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. Journal of Immunology (Baltimore, Md. : 1950). 184: 4423-30. PMID 20212098 DOI: 10.4049/jimmunol.0903955  0.96
2010 Verma B, Hawkins OE, Neethling FA, Caseltine SL, Largo SR, Hildebrand WH, Weidanz JA. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunology, Immunotherapy : Cii. 59: 563-73. PMID 19779714 DOI: 10.1007/s00262-009-0774-8  0.96
2010 Wahl A, Schafer F, Bardet W, Hildebrand WH. HLA class I molecules reflect an altered host proteome after influenza virus infection. Human Immunology. 71: 14-22. PMID 19748539 DOI: 10.1016/j.humimm.2009.08.012  0.96
2009 Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, Scharf L, Trott DL, Ndonye RM, Veerapen N, Besra GS, Howell AR, Cook ME, Adams EJ, Hildebrand WH, Gumperz JE. Recognition of lyso-phospholipids by human natural killer T lymphocytes. Plos Biology. 7: e1000228. PMID 19859526 DOI: 10.1371/journal.pbio.1000228  0.96
2009 Wahl A, McCoy W, Schafer F, Bardet W, Buchli R, Fremont DH, Hildebrand WH. T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. Journal of Virology. 83: 9206-14. PMID 19553306 DOI: 10.1128/JVI.00932-09  0.96
2009 Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, Wahl A, Hawkins OE, Piaskowski S, Wilson NA, Hildebrand WH, Watkins DI, Sette A. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. Journal of Immunology (Baltimore, Md. : 1950). 182: 7763-75. PMID 19494300 DOI: 10.4049/jimmunol.0900111  0.96
2009 Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunology, Immunotherapy : Cii. 58: 1419-31. PMID 19184004 DOI: 10.1007/s00262-009-0657-z  0.96
2009 Wahl A, Schafer F, Bardet W, Buchli R, Air GM, Hildebrand WH. HLA class I molecules consistently present internal influenza epitopes. Proceedings of the National Academy of Sciences of the United States of America. 106: 540-5. PMID 19122146 DOI: 10.1073/pnas.0811271106  0.96
2009 Hempel U, Buranapraditkun S, Chatkulkawin P, Pitakpolrat P, Phillips LC, Allgaier RL, Lorenzen S, Hildebrand WH, Leitner T, Matthews P, Goulder P, Walker BD, Ruxrungtham K, Allen TM. P16-07. HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P236  0.96
2008 Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH. Identification of breast cancer peptide epitopes presented by HLA-A*0201. Journal of Proteome Research. 7: 1445-57. PMID 18345606 DOI: 10.1021/pr700761w  0.96
2008 McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH. Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes. Proceedings of the National Academy of Sciences of the United States of America. 105: 2981-6. PMID 18299564 DOI: 10.1073/pnas.0711874105  0.96
2007 Hurley CK, Fernandez-Vina M, Hildebrand WH, Noreen HJ, Trachtenberg E, Williams TM, Baxter-Lowe LA, Begovich AB, Petersdorf E, Selvakumar A, Stastny P, Hegland J, Hartzman RJ, Carston M, Gandham S, et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Human Immunology. 68: 30-40. PMID 17207710 DOI: 10.1016/j.humimm.2006.09.004  0.96
2007 Weidanz JA, Piazza P, Hickman-Miller H, Woodburn D, Nguyen T, Wahl A, Neethling F, Chiriva-Internati M, Rinaldo CR, Hildebrand WH. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. Journal of Immunological Methods. 318: 47-58. PMID 17134715 DOI: 10.1016/j.jim.2006.09.019  0.96
2006 Weidanz JA, Nguyen T, Woodburn T, Neethling FA, Chiriva-Internati M, Hildebrand WH, Lustgarten J. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. Journal of Immunology (Baltimore, Md. : 1950). 177: 5088-97. PMID 17015692  0.96
2006 Buchli R, Vangundy RS, Giberson CF, Hildebrand WH. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. Journal of Immunological Methods. 314: 38-53. PMID 16844138 DOI: 10.1016/j.jim.2006.05.010  0.96
2005 Loffredo JT, Sidney J, Piaskowski S, Szymanski A, Furlott J, Rudersdorf R, Reed J, Peters B, Hickman-Miller HD, Bardet W, Rehrauer WM, O'Connor DH, Wilson NA, Hildebrand WH, Sette A, et al. The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. Journal of Immunology (Baltimore, Md. : 1950). 175: 5986-97. PMID 16237093  0.96
2005 Wren JD, Hildebrand WH, Chandrasekaran S, Melcher U. Markov model recognition and classification of DNA/protein sequences within large text databases. Bioinformatics (Oxford, England). 21: 4046-53. PMID 16159926 DOI: 10.1093/bioinformatics/bti657  0.96
2005 Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. Biochemistry. 44: 12491-507. PMID 16156661 DOI: 10.1021/bi050255v  0.96
2005 Hickman-Miller HD, Bardet W, Gilb A, Luis AD, Jackson KW, Watkins DI, Hildebrand WH. Rhesus macaque MHC class I molecules present HLA-B-like peptides. Journal of Immunology (Baltimore, Md. : 1950). 175: 367-75. PMID 15972670  0.96
2005 Huang XL, Fan Z, Colleton BA, Buchli R, Li H, Hildebrand WH, Rinaldo CR. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. Journal of Virology. 79: 3052-62. PMID 15709025 DOI: 10.1128/JVI.79.5.3052-3062.2005  0.96
2005 Petersen JL, Hickman-Miller HD, McIlhaney MM, Vargas SE, Purcell AW, Hildebrand WH, Solheim JC. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. Journal of Immunology (Baltimore, Md. : 1950). 174: 962-9. PMID 15634919  0.96
2004 Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry. 43: 14852-63. PMID 15544356 DOI: 10.1021/bi048580q  0.96
2004 Hickman-Miller HD, Hildebrand WH. The immune response under stress: the role of HSP-derived peptides. Trends in Immunology. 25: 427-33. PMID 15275642 DOI: 10.1016/j.it.2004.05.011  0.96
2004 Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA. HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Der Urologe. Ausg. A. 43: S137. PMID 15148575 DOI: 10.1007/s00120-004-0603-9  0.96
2004 Hickman HD, Luis AD, Buchli R, Few SR, Sathiamurthy M, VanGundy RS, Giberson CF, Hildebrand WH. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. Journal of Immunology (Baltimore, Md. : 1950). 172: 2944-52. PMID 14978097  0.96
2004 Leffell MS, Fallin MD, Hildebrand WH, Cavett JW, Iglehart BA, Zachary AA. HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III. Human Immunology. 65: 78-89. PMID 14700599 DOI: 10.1016/j.humimm.2003.10.001  0.96
2003 Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, Shearer MH, Jackson KW, Kennedy RC, Hildebrand WH. Cutting edge: class I presentation of host peptides following HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 171: 22-6. PMID 12816978  0.96
2003 Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA. Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. The Journal of Urology. 169: 2084-8. PMID 12771724 DOI: 10.1097/01.ju.0000065810.80617.f4  0.96
2003 Sathiamurthy M, Hickman HD, Cavett JW, Zahoor A, Prilliman K, Metcalf S, Fernandez Vina MA, Hildebrand WH. Population of the HLA ligand database Tissue Antigens. 61: 12-19. PMID 12622773 DOI: 10.1034/j.1399-0039.2003.610102.x  0.96
2003 Huang XL, Fan Z, Zheng L, Borowski L, Li H, Thomas EK, Hildebrand WH, Zhao XQ, Rinaldo CR. Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins. The Journal of Infectious Diseases. 187: 315-9. PMID 12552458 DOI: 10.1086/346054  0.96
2002 Leffell MS, Fallin MD, Erlich HA, Fernandez-Vĩna M, Hildebrand WH, Mack SJ, Zachary AA. HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II. Human Immunology. 63: 614-25. PMID 12072196 DOI: 10.1016/S0198-8859(02)00415-9  0.96
2002 Hildebrand WH, Turnquist HR, Prilliman KR, Hickman HD, Schenk EL, McIlhaney MM, Solheim JC. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Human Immunology. 63: 248-55. PMID 12039406 DOI: 10.1016/S0198-8859(02)00364-6  0.96
2002 Wang QJ, Huang XL, Rappocciolo G, Jenkins FJ, Hildebrand WH, Fan Z, Thomas EK, Rinaldo CR. Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood. 99: 3360-6. PMID 11964304 DOI: 10.1182/blood.V99.9.3360  0.96
2002 Turnquist HR, Schenk EL, McIlhaney MM, Hickman HD, Hildebrand WH, Solheim JC. Disparate binding of chaperone proteins by HLA-A subtypes. Immunogenetics. 53: 830-4. PMID 11862383 DOI: 10.1007/s00251-001-0404-x  0.96
2001 Wu S, Shiao YM, Lai SM, Lai CY, Chen SP, Chen YF, Sidebottom DA, Hildebrand WH, Chou FC, Tsai MF. New DR5 sequences: a novel DRB1*11122 allele identified in Paiwan tribe members of Taiwan and a corrected sequence for the DRB1*1201 allele. Tissue Antigens. 58: 193-7. PMID 11703830 DOI: 10.1034/j.1399-0039.2001.580310.x  0.96
2001 Ellexson-Turner ME, Leffell MS, Zachary AA, Turner S, Bennett T, Sidebottom DA, Cao K, Fernández-Viña M, Hildebrand WH. Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo Human Immunology. 62: 639-644. PMID 11390039 DOI: 10.1016/S0198-8859(01)00243-9  0.96
2001 Wu S, Shiao YM, Lai CY, Lai SM, Chen SP, Sidebottom DA, Hildebrand WH, Tilanus MGJ, Chou FC, Tsai MF. Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB1*15011) and DR6 (DRB1*1405) alleles: A novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan Tissue Antigens. 57: 384-387. PMID 11380954 DOI: 10.1034/j.1399-0039.2001.057004384.x  0.96
2001 Hickman HD, Cavett JW, Ellexson-Turner ME, Sparkman JN, Bennett TT, Turner S, Sidebottom DA, Trachtenberg EA, Confer DL, Hildebrand WH. Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules Tissue Antigens. 57: 95-102. PMID 11260503 DOI: 10.1034/j.1399-0039.2001.057002095.x  0.96
2001 Sidebottom DA, Kennedy R, Hildebrand WH. Class I MHC expression in the yellow baboon Journal of Immunology. 166: 3983-3993. PMID 11238644  0.96
2001 Ellexson-Turner M, Sidebottom D, Turner S, Bennett T, Hildebrand WH. Precision genotyping of human leukocyte antigen-A, -B and -C loci via direct DNA sequencing Methods in Molecular Biology (Clifton, N.J.). 156: 129-142. PMID 11068755  0.96
2001 Hickman HD, Shearer MH, Sparkman JN, Battson CL, Jackson KW, Kennedy RC, Hildebrand WH. Pathogen-derived MHC class I ligand identification in HIV-1 infected cells European Journal of Immunogenetics. 28: 220.  0.96
2000 Hickman HD, Batson CL, Prilliman KR, Crawford DL, Jackson KL, Hildebrand WH. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. Human Immunology. 61: 1339-46. PMID 11163091 DOI: 10.1016/S0198-8859(00)00216-0  0.96
2000 Turnquist HR, Thomas HJ, Prilliman KR, Lutz CT, Hildebrand WH, Solheim JC. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. European Journal of Immunology. 30: 3021-8. PMID 11069086 DOI: 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U  0.96
2000 Rinaldo CR, Huang XL, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, Mcmahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW. Anti-human immunodeficiency virus type 1 (HIV-1) CD8+ T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency Journal of Virology. 74: 4127-4138. PMID 10756025 DOI: 10.1128/JVI.74.9.4127-4138.2000  0.96
1999 Prilliman KR, Crawford D, Hickman HD, Jackson KW, Wang J, Hildebrand WH. Alpha-2 domain polymorphism and HLA class I peptide loading. Tissue Antigens. 54: 450-60. PMID 10599884 DOI: 10.1034/j.1399-0039.1999.540502.x  0.96
1999 Prilliman KR, Jackson KW, Lindsey M, Wang J, Crawford D, Hildebrand WH. HLA-B15 peptide ligands are preferentially anchored at their C termini. Journal of Immunology (Baltimore, Md. : 1950). 162: 7277-84. PMID 10358176  0.96
1999 Prilliman KR, Lindsey M, Wang J, Jackson KW, Hildebrand WH. Peptide motif of the class I molecule HLA-B*1503 Immunogenetics. 49: 144-146. PMID 9887352 DOI: 10.1007/s002510050474  0.96
1998 Turner S, Ellexson ME, Hickman HD, Sidebottom DA, Fernández-Viña M, Confer DL, Hildebrand WH. Sequence-based typing provides a new look at HLA-C diversity Journal of Immunology. 161: 1406-1413. PMID 9686604  0.96
1998 Ellexson ME, Peck RL, Stewart D, Keller J, Hildebrand WH. Characterization of an HLA-A26 serologic variant Immunogenetics. 48: 152-155. PMID 9634481 DOI: 10.1007/s002510050417  0.96
1998 Prilliman KR, Lindsey M, Jackson KW, Cole J, Bonner R, Hildebrand WH. Complexity among constituents of the HLA-B*1501 peptide motif Immunogenetics. 48: 89-97. PMID 9634472 DOI: 10.1007/s002510050408  0.96
1997 Kennedy RC, Shearer MH, Hildebrand WH, Simmonds RS. Nonhuman primates and their potential use in immunologically based investigations Immunologist. 5: 150-156.  0.96
1996 Chandanayingyong D, Adams EJ, Arnett KL, Hildebrand WH, Parham P, Lau M. The presence of HLA-A*2403 and HLA-B*1512 on the same haplotype in a Thai family. Tissue Antigens. 47: 426-7. PMID 8795144  0.96
1994 Hildebrand WH, Domena JD, Shen SY, Marsh SG, Bunce M, Guttridge MG, Darke C, Parham P. The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708) Tissue Antigens. 44: 47-51. PMID 7974468  0.96
1994 Parham P, Arnett KL, Adams EJ, Barber LD, Domena JD, Stewart D, Hildebrand WH, Little AM. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens. 43: 302-13. PMID 7524186  0.96
1994 Hildebrand WH, Domena JD, Shen SY, Lau M, Terasaki PI, Bunce M, Marsh SGE, Guttridge MG, Bias WB, Parham P. HLA-B15: A widespread and diverse family of HLA-B alleles Tissue Antigens. 43: 209-218. PMID 7521976  0.96
1994 Little AM, Domena JD, Hildebrand WH, Shen SY, Barber LD, Marsh SGE, Bias WB, Parham P. HLA-B67: A member of the HLA-:B16 family that expresses the ME1 epitope Tissue Antigens. 43: 38-43. PMID 7517584  0.96
1993 Madrigal JA, Hildebrand WH, Belich MP, Benjamin RJ, Little AM, Zemmour J, Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED. Structural diversity in the HLA-A10 family of alleles: correlations with serology. Tissue Antigens. 41: 72-80. PMID 8475492  0.96
1993 Hildebrand WH, Domena JD, Parham P. Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8 Tissue Antigens. 41: 190-195. PMID 8362411  0.96
1993 Domena JD, Hildebrand WH, Bias WB, Parham P. A sixth family of HLA-A alleles defined by HLA-A(*)8001 Tissue Antigens. 42: 156-159. PMID 8284791  0.96
1993 Domena JD, Little AM, Madrigal AJ, Hildebrand WH, Johnston-Dow L, Du Toit E, Bias WB, Parham P. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations Tissue Antigens. 42: 509-517. PMID 8146861  0.96
1992 Hildebrand WH, Madrigal JA, Little AM, Parham P. HLA-Bw22: A family of molecules with identity to HLA-B7 in the α1-helix Journal of Immunology. 148: 1155-1162. PMID 1737933  0.96
1992 Hildebrand WH, Horton RM, Pease LR, Martinko JM. Nucleotide sequence analysis of H-2Df and the spontaneous in vivoH-2Dfm2 mutation Molecular Immunology. 29: 61-69. PMID 1731192 DOI: 10.1016/0161-5890(92)90157-S  0.96
1992 Madrigal JA, Belich MP, Hildebrand WH, Benjamin RJ, Little AM, Zemmour J, Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED. Distinctive HLA-A,B antigens of black populations formed by interallelic conversion. Journal of Immunology (Baltimore, Md. : 1950). 149: 3411-5. PMID 1431115  0.96
1992 Kawaguchi G, Hildebrand WH, Hiraiwa M, Karaki S, Nagao T, Akiyama N, Uchida H, Kashiwase K, Akaza T, Williams RC, Juji T, Parham P, Takiguchi M. Two subtypes of HLA-B51 differing by substitution at position 171 of the α2 helix Immunogenetics. 37: 57-63. PMID 1428012 DOI: 10.1007/BF00223545  0.96
1992 Hildebrand WH, Alejandro Madrigal J, Belich MP, Zemmour J, Ward FE, Williams RG, Parham P. Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups: Dominant epitopes of the α2 helix 1,2 Journal of Immunology. 149: 3563-3568. PMID 1385528  0.96
1992 Zemmour J, Gumperz JE, Hildebrand WH, Ward FE, Marsh SGE, Williams RC, Parham P. The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes Tissue Antigens. 39: 249-257. PMID 1384166  0.96
1992 Belich MP, Madrigal JA, Hildebrand WH, Zemmour J, Williams RC, Luz R, Petzl-Erler ML, Parham P. Unusual HLA-B alleles in two tribes of Brazilian Indians Nature. 357: 326-329. PMID 1317015  0.96
1991 Rubocki RJ, Connolly JM, Hansen TH, Melvold RW, Kim BS, Hildebrand WH, Martinko J. Mutation at amino acid position 133 of H-2Dd prevents β2m association and immune recognition but not surface expression Journal of Immunology. 146: 2352-2357. PMID 2005403  0.96
1991 Madrigal JA, Belich MP, Benjamin RJ, Little AM, Hildebrand WH, Mann DL, Parham P. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. The Journal of Experimental Medicine. 174: 1085-95. PMID 1940790  0.96
1990 Horton RM, Hildebrand WH, Martinko JM, Pease LR. Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences Journal of Immunology. 145: 1782-1787. PMID 2391419  0.96
Show low-probability matches.